Pay in 4 interest-free payments of $6.70 Learn more
Ships within 48 hours Β· Estimated delivery Aug 10 - Aug 15
Stay away from heavy alcohol drinking
It remains an investigational compound, and its use in clinical settings is considered off-label
Off-Label Usage Investigated for weight management and obesity, though Wegovy (injectable semaglutide) is specifically approved for this
You will learn about the common side effects, what to do if you experience them, and when to seek medical help
Summary table of pivot efficiency In published trials, the difference between retatrutide, tirzepatide, and semaglutide is significant: switching from semaglutide to retatrutide nearly doubles the average weight loss
US$ 26.56
US$ 25.97
US$ 20.83
US$ 21.10
